EDITORIAL
Published on 15 Dec 2014
Mitochondrial Proteins (e.g., VDAC, Bcl-2, HK, ANT) as Major Control Points in Oncology
doi 10.3389/fonc.2014.00365
- 3,245 views
- 4 citations
- Frontiers in Oncology
- Molecular and Cellular Oncology
- Research Topics
- Mitochondrial proteins (e.g. VDAC, Bcl-2, HK, ANT2...) as major control points in oncology
Mitochondrial proteins (e.g. VDAC, Bcl-2, HK, ANT2...) as major control points in oncology
18k
Total downloads
99k
Total views and downloads
Articles
REVIEW
Published on 08 Mar 2013
Mitochondrial permeability transition pore as a selective target for anti-cancer therapy
doi 10.3389/fonc.2013.00041
- 11,576 views
- 68 citations
REVIEW
Published on 07 Mar 2013
Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology
doi 10.3389/fonc.2013.00038
- 30,898 views
- 226 citations
MINI REVIEW
Published on 05 Feb 2013
GSK-3 and mitochondria in cancer cells
doi 10.3389/fonc.2013.00016
- 9,046 views
- 59 citations
REVIEW
Published on 02 Jan 2013
Crosstalk between Bcl-2 family and Ras family small GTPases: potential cell fate regulation?
doi 10.3389/fonc.2012.00206
- 4,944 views
- 23 citations
REVIEW
Published on 29 Nov 2012
VDAC1: from structure to cancer therapy
doi 10.3389/fonc.2012.00164
- 25,073 views
- 170 citations
REVIEW
Published on 08 Oct 2012
Shifting the balance of mitochondrial apoptosis: therapeutic perspectives
doi 10.3389/fonc.2012.00121
- 5,052 views
- 22 citations
MINI REVIEW
Published on 02 Oct 2012
Reprofiling a classical anthelmintic, pyrvinium pamoate, as an anti-cancer drug targeting mitochondrial respiration
doi 10.3389/fonc.2012.00137
- 15,784 views
- 53 citations
